September 23, 2016 – ArisGlobal®, a leading provider of integrated, cloud-based software solutions for life sciences, today welcomes Dr. Krishna Bahadursingh as the organization’s Senior Vice President of Safety and Risk Management. As a preeminent expert in safety and pharmacovigilance, Dr. Bahadursingh brings more than 17 years of experience to ArisGlobal’s leadership team, most recently serving as Merck’s executive head of Pharmacovigilance and Risk Management in Japan.
“Dr. Bahadursingh is highly respected throughout the industry,” said ArisGlobal CEO Deepak Abbhi. “Adding an executive of his caliber signals to our partners, clients and peers that we are committed to shaping the future of life sciences with multi-faceted, bold and innovative leaders like Dr. Bahadursingh.”
Dr. Bahadursingh’s well recognized breadth of experience affords him a unique perspective and expertise in developing comprehensive solutions to life sciences organizations’ most pressing safety challenges. He joined the pharma industry from clinical practice, after which he spent over a decade in multi-disciplinary leadership roles central to ensuring patient safety and regulatory compliance at Eisai, Co., Ltd.’s Tokyo headquarters. In addition to his medical experience, Dr. Bahadursingh holds an Executive MBA from McGill University in Montreal, Canada and is also an attorney-at-law, specializing in medical jurisprudence in both the United Kingdom and Canada.
In his new role, Dr. Bahadursingh will play a pivotal role in executing vision for ArisGlobal’s extensive suite of cloud-based safety products, including ARISg, ArisGlobal’s best-in-class core case management system (learn more).
“ArisGlobal has established a 30-year heritage in delivering leading pharmacovigilance and safety solutions,” said Dr. Bahadursingh. “I look forward to continuing that proud tradition of innovation across all of our products, and empowering our clients to provide the most robust and regulatory compliant drug safety management solutions possible to ensure favorable patient outcomes.”
ArisGlobal’s cloud-based solutions facilitate global drug development and regulatory compliance within the life sciences and healthcare industries. Its cloud platform supports the entire product life cycle including clinical development, regulatory affairs, pharmacovigilance and medical communications. Hundreds of drug and device manufacturers, CROs and regulatory agencies leverage ArisGlobal’s advanced technology solutions to make better and more informed decisions, facilitate compliance, reduce risk, and improve operational efficiency. Headquartered in the United States, ArisGlobal® has regional offices in Europe, India and Japan. For more information, visit arisglobal.com.